Faron Pharmaceuticals Investor Relations Material
Latest events
Study Result
Faron Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Faron Pharmaceuticals
Access all reports
Faron Pharmaceuticals is a Finland-based clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer and other serious conditions. The company’s research targets immune system modulation to treat aggressive diseases with unmet medical needs. Faron Pharmaceuticals is headquartered in Turku, Finland, and its shares are listed on the AIM.
Key slides for Faron Pharmaceuticals
CMD 2024
Faron Pharmaceuticals
CMD 2024
Faron Pharmaceuticals
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
FARON
Country
🇫🇮 Finland